Urine and bladder washing cytology for detection of urothelial carcinoma: standard test with new possibilities
By: Margareta Flezar
Open Access
|Sep 2010References
- Grunze H, Springss AI. History of clinical cytology. A selection of documents. Darmstadt: G-I-T Verlag Ernst Giebler; 1980.
- Koss LG. The lower urinary tract in the absence of cancer. In: Koss LG, Melamed MR, editors. Koss's diagnostic cytology and its histopathologic bases. 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 738-776.
- Grossfeld GD, Litwin MS, Wolf JS Jr, Hirack H, Shuler CL, Agerter DC, et al. Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association best practice policy - part I: definition, detection, prevalence, and etiology. Urology 2001; 57: 599-603.
- Grossfeld GD, Litwin MS, Wolf JS Jr, Hirack H, Shuler CL, Agerter DC, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy - part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology 2001; 57: 604-10.
- Koss LG. Tumors of the urinary tract in urine and brushings. In: Koss LG, Melamed MR, editors. Koss's diagnostic cytology and its histopathologic bases. 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 777-846.
- Rosenthal DL, Raab SS. Cytologic detection of urothelial lesions. In: Rosenthal DL, editors. Essentials in cytopathology series. New York: Springer; 2005. p. 57-62.
- http://www.thinprep.com/
- Lopes-Beltran A, Sauter G, Gasser T, Hartman A, Schmitz-Dräger BJ, Helpap B, et al. Infiltrating urothelial carcinoma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. WHO classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004. p. 93-109.
- Sauter G, Algaba F, Amin MB, Busch C, Cheville J, Gasser T, et al. Noninvasive urothelial tumors. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. WHO classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004. p.110-9.
- Bastacky S, Ibrahim S, Wilczynski SP, Murphy WM. The accuracy of urinary cytology in daily practice. Cancer (Cancer Cytopathol) 1999; 87: 118-28.
- Curry JL, Wojcik EM. The effect of the current World Health Organisation/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results. Cancer 2002; 96: 140-5.
- Greene LF, Hanash KA, Farrow GM. Benign papilloma or papillary carcinoma of the bladder? J Urol 1973; 110: 205-7.
- Ross JS, Cohen MB. Ancillary methods for the detection of reccurent urothelial neoplasia. Cancer 2000; 90: 75-86.
- Us-Krašovec M. Pretočna in slikovna citometrija: novi kvantitativni metodi. Onkologija 1998; 2: 40-2.
- Böcking A, Striepecke E, Auer H, Füzesi L. Static DNA cytometry. Biological background, technique and diagnostic interpretation. In: Wied GL, Bartels PH, Rosenthal D, Schenk U, editors. Compendium on computerized cytology and histology laboratory. Chicago: Tutorials of cytology; 1994. p. 107-28.
- Tribukait B. Flow cytometry in assessing the clinical agressiveness of genitourinary neoplasms. World J Urol 1987; 5: 108-22.
- Sullivan PS, Nooraie F, Sanchez H, Hirschowitz S, Levin M, Rao PN, et al. Comparison of ImmunoCyt, UroVysion and urine cytology in detection of recurrent urothelial carcinoma: a "split-sample" study. Cancer Cytopathol 2009; 117: 167-73.
- Tętu B. Diagnosis of urothelial carcinoma from urine. Modern Pathol 2009; 22: S53-9.
- Soloway MS, Briggman V, Carpinito GA, Chodak GW, Church PA, Lamm DL, et al. Use of a new tumor marker, urinary NMP22, in the detection of occult and rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 1996; 156: 363-7.
- Nguyen CT, Jones JS. Defining the role of NMP22 in bladder cancer surveillance. World J Urol 2008; 26: 51-8.
- Richter J, Beffa L, Wagner U, Schraml P, Gasser TC, Moch H, et al. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol 1998; 153: 1615-21.
- Zhao J, Richter J, Wagner U, Roth B, Schraml P, Zellweger T, et al. Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res 1999; 59: 4658-61.
- Sokolova IA, Halling KC, Jenkins RB, Burkhardt HM, Meyer RG, Seeling SA, et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diag 2000; 2: 116-23.
- http://www.urovysion.com/
- Bubendorf L, Grilli B, Sauter G, Mihatsch MJ, Gaser TC, Dalquen P. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 2001; 116: 79-86.
- Yoder BJ, Skacel M, Hedgepeth R, Babineau D, Ulchaker JC, Liou LS, et al. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative cytology: a prospective study with focus on the natural history of anticipatory positive findings. Am J Clin Pathol 2007; 127: 295-301.
- Kipp BR, Tanasescu M, Else TA, Bryant SC, Karnes RJ, Sebo TJ, et al. Quantitative fluorescent in situ hybridisation and its ability to predict bladder cancer recurrence and progression to muscle invasive bladder cancer. J Mol Diagn 2009; 11: 148-54.
- Halling KC, Kipp BR. Fluorescence in situ hybridization in diagnostic cytology. Hum Pathol 2007; 38: 1137-44.
- Schmitt FC, Longatto-Filho A, Valent A, Vielh P. Molecular techniques in cytopathology practice. J Clin Pathol 2008; 61: 258-67.
- Cancer Registry of Slovenia. Cancer incidence in Slovenia 2006. Report No. 48. Ljubljana: Institute of Oncology; 2009.
Language: English
Page range: 207 - 214
Published on: Sep 29, 2010
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2010 Margareta Flezar, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.